日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents

使用库沙珠单抗靶向 CD70 可消除接受低甲基化药物治疗的患者的急性髓系白血病干细胞

Carsten Riether, Thomas Pabst, Sabine Höpner, Ulrike Bacher, Magdalena Hinterbrandner, Yara Banz, Rouven Müller, Markus G Manz, Walid H Gharib, David Francisco, Remy Bruggmann, Luc van Rompaey, Mahan Moshir, Tim Delahaye, Domenica Gandini, Ellen Erzeel, Anna Hultberg, Samson Fung, Hans de Haard, Nic

Complement inhibition prevents glial nodal membrane injury in a GM1 antibody-mediated mouse model

补体抑制可预防GM1抗体介导的小鼠模型中的神经胶质结节膜损伤

Clare I Campbell ,Rhona McGonigal ,Jennifer A Barrie ,Jolien Delaere ,Laura Bracke ,Madeleine E Cunningham ,Denggao Yao ,Tim Delahaye ,Inge Van de Walle ,Hugh J Willison

An open-label, nonrandomized, phase Ib feasibility study of cusatuzumab in patients with nasopharyngeal carcinoma

一项针对鼻咽癌患者使用库沙珠单抗的开放标签、非随机 Ib 期可行性研究

Astrid De Meulenaere, Tijl Vermassen, David Creytens, Stijn De Keukeleire, Tim Delahaye, Philippe Deron, Fréderic Duprez, Samson Fung, Patrick Pauwels, Liesbeth Ferdinande, Sylvie Rottey